Eczema

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.

BOSTON — About one-third of children with atopic dermatitis saw mild improvements with elimination diets, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

October is National Eczema Awareness Month. It serves to bring attention to the approximately 16.5 million adults and 8 million children in the U.S. that currently suffer from the chronic skin condition.

The National Eczema Association has dedicated October to raising awareness of this inflammatory skin condition, with 2024 focused on reducing stigma using social media.

The new drug application for delgocitinib cream 2% has been accepted by the FDA for the treatment of patients with moderate to severe chronic hand eczema, LEO Pharma announced in a press release.

A new study finds that the majority of patients with chronic hand eczema suffer from corticosteroid phobia, which negatively impacts treatment adherence.

Children with diverse skin types with atopic dermatitis-prone skin did not experience any adverse events when using a sunscreen formulated with antioxidants, according to a study.

SAN ANTONIO — Different patterns of allergic contact dermatitis on the head and face may provide clues about what caused these outbreaks, Heather O’Connell, PA-C, said at the 16th Annual Allergy, Asthma & Immunology CME Conference.

Delgocitinib cream has shown efficacy in the treatment of hand eczema in two phase 3 trials.

The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended the approval of Anzupgo for the treatment of chronic hand eczema in adults, LEO Pharma announced in a press release.